Intellectual Property

Refine by:
Cross search by:
Researchers at the UW Medicine Retrovirology Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trials on February 12, 2021 in Seattle, Washington. (Photo by Karen Ducey/Getty Images)
Researchers at the UW Medicine Retrovirology Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trials on February 12, 2021 in Seattle, Washington. (Photo by Karen Ducey/Getty Images)
Commentary
Waiving Vaccine Patents Would Imperil Public Health
Adam Mossoff
Adam Mossoff
Adam Mossoff
Chair, Forum for Intellectual Property and Senior Fellow
Adam Mossoff
Commentary
3 Min Read
The Facebook CEO, Mark Zuckerberg, testified before the House Financial Services Committee on Wednesday October 23, 2019 Washington, D.C. (Photo by Aurora Samperio/NurPhoto via Getty Images)
The Facebook CEO, Mark Zuckerberg, testified before the House Financial Services Committee on Wednesday October 23, 2019 Washington, D.C. (Photo by Aurora Samperio/NurPhoto via Getty Images)
Commentary
Section 230 Turns 25. May It Reach 50
kirk-arner
kirk-arner
Kirk R. Arner
Former Legal Fellow, Center for the Economics of the Internet
harold_furchtgott_roth
harold_furchtgott_roth
Harold Furchtgott-Roth
Senior Fellow and Director, Center for the Economics of the Internet
Kirk R. Arner & Harold Furchtgott-Roth
Commentary
5 Min Read
Experts
View All Experts
stay informed putin
Stay Informed.

Sign up for our newsletter and get the latest insights and analysis you won’t find anywhere else tailored to the topics that matter to you.

Subscribe Now